Physician profile
Chad E Potteiger
NPI 1346205358
$2,939.54
in general payments reported to CMS, 2019-2025
16 companies · $518 in 2025
The $518 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.83 · 2020: $150 · 2021: $620 · 2022: $452 · 2023: $682 · 2024: $454 · 2025: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,654.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,758.17 | 2019-2025 | |
| Janssen Biotech, INC. | $385.17 | 2020-2025 | Tremfya, Stelara, Remicade |
| Ironwood Pharmaceuticals, INC | $207.40 | 2020-2023 | Linzess |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $148.93 | 2019-2025 | Xifaxan |
| Celgene Corporation | $112.02 | 2021-2024 | Zeposia |
| Regeneron Healthcare Solutions, INC. | $87.53 | 2022-2024 | Dupixent |
| Intercept Pharmaceuticals, INC. | $62.59 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.53 | 2019-2023 | Gattex |
| Ardelyx, INC. | $31.28 | 2023 | Ibsrela |
| Nestle Healthcare Nutrition INC. | $24.98 | 2020-2021 | |
| Gilead Sciences, INC. | $15.72 | 2020 | |
| Lucid Diagnostics INC. | $15.44 | 2023 | |
| Genzyme Corporation | $15.24 | 2023 | |
| Allergan, INC. | $12.86 | 2019 | |
| Merck Sharp & Dohme LLC | $11.85 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $8.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Potteiger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.